Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Business News › HalioDx Inks Israeli Distribution Deal for Colon Cancer Assay

HalioDx Inks Israeli Distribution Deal for Colon Cancer Assay

Jul 31, 2018
|
staff reporter

NEW YORK (360Dx) — HalioDx announced today that it has signed a distribution agreement for its Immunoscore colon cancer assay in Israel with Pronto Diagnostics.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

What's Popular?

In Immunoassays

  1. With Luminex Acquisition, DiaSorin to Broaden MDx Portfolio, Expand US Presence

    Premium

  2. Siemens Healthineers Gets CE Mark for Point-of-Care High-Sensitivity Cardiac Troponin I Test

  3. FDA Grants EUAs for SARS-CoV-2 Tests From Clinical Enterprise, Qorvo Biotechnologies

  4. GenScript Biotech, IES Diagnostics Partner to Distribute SARS-CoV-2 Antibody Kit

  5. Ortho Clinical Diagnostics Gets Additional CE Mark for Coronavirus Antigen Test

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.